Definitive Healthcare (NASDAQ:DH) Price Target Cut to $6.00 by Analysts at Barclays

Definitive Healthcare (NASDAQ:DH) had its price objective decreased by investment analysts at Barclays from $7.00 to $6.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target points to a potential upside of 75.95% from the stock’s current price.

A number of other analysts have also recently commented on DH. William Blair reaffirmed an “outperform” rating on shares of Definitive Healthcare in a research report on Tuesday, May 14th. Canaccord Genuity Group cut their price target on shares of Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating on the stock in a research report on Wednesday, May 8th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating on the stock in a research report on Thursday, May 9th. Finally, Morgan Stanley cut shares of Definitive Healthcare from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $11.50 to $9.00 in a research report on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $8.65.

Definitive Healthcare Trading Down 40.6 %

DH traded down $2.33 during trading on Wednesday, reaching $3.41. 1,267,531 shares of the stock traded hands, compared to its average volume of 713,899. The company has a quick ratio of 2.30, a current ratio of 2.30 and a debt-to-equity ratio of 0.20. The stock has a market capitalization of $402.14 million, a PE ratio of -1.95, a P/E/G ratio of 4.32 and a beta of 1.30. The stock’s 50-day moving average is $5.55 and its 200 day moving average is $7.14. Definitive Healthcare has a 12 month low of $3.35 and a 12 month high of $11.97.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). The firm had revenue of $63.48 million for the quarter, compared to the consensus estimate of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. Equities analysts anticipate that Definitive Healthcare will post 0.1 earnings per share for the current year.

Institutional Investors Weigh In On Definitive Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Massachusetts Financial Services Co. MA increased its stake in Definitive Healthcare by 76.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,466,514 shares of the company’s stock valued at $34,457,000 after buying an additional 1,496,652 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Definitive Healthcare by 6.2% in the 3rd quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock worth $34,609,000 after buying an additional 254,726 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Definitive Healthcare by 209.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock worth $161,000 after buying an additional 10,977 shares during the period. Susquehanna Fundamental Investments LLC bought a new position in Definitive Healthcare in the 1st quarter worth approximately $120,000. Finally, Swiss National Bank boosted its holdings in Definitive Healthcare by 2.9% in the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after buying an additional 2,900 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.